|  | Coronavirus |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 4274 | AP 24534 | Identified as
  targeting human proteins in the SARS-CoV-2 interactome | 
 
  |  | 7283 | Apilimod
  dimesylate | Inhibits
  cellular entry by SARS-CoV-2, MERS-CoV and MHV S pseudovirions | 
 
  |  | 7235 | Arbidol | Inhibits
  replication of SARS-CoV-2 in vitro; broad spectrum antiviral | 
 
  |  | 4600 | Auranofin | Inhibits
  SARS-CoV-2 infection in vitro | 
 
  |  | 3771 | Azithromycin | Predicted
  to disrupt binding of SARS-CoV-2 spike protein to ACE2 | 
 
  |  | 7222 | Baricitinib | In
  silico modelling predicts inhibition of SARS-CoV-2
  cell entry; highly potent JAK inhibitor | 
 
  |  | 3193 | Camostat
  mesylate | Inhibits
  entry of SARS-Cov-2 into lung cells; TMPRSS2 inhibitor | 
 
  |  | 4109 | Chloroquine
  diphosphate | Inhibits
  SARS-CoV-2 infection in vitro | 
 
  |  | 6357 | Ciclesonide | Inhibits
  replication of SARS-CoV-2 in vitro; glucocorticoid | 
 
  |  | 0460 | Cinanserin
  hydrochloride | Inhibits
  replication of SARS-CoV; Mpro inhibitor and 5-HT2 antagonist | 
 
  |  | 0970 | Cycloheximide | Exhibits
  anti-MERS-CoV activity in vitro; protein synthesis inhibitor | 
 
  |  | 1101 | Cyclosporin
  A | Inhibits
  coronavirus replication; cyclophilin inhibitor | 
 
  |  | 7223 | Dabrafenib
  mesylate | Targets
  human proteins in the SARS-CoV-2 interactome | 
 
  |  | 1467 | Daunorubicin
  hydrochloride | Identified
  as targeting human proteins in the SARS-CoV-2 interactome | 
 
  |  | 4583 | Digoxin | Exhibits
  anti-MERS-CoV activity in vitro; Na+/K+ ATPase inhibitor | 
 
  |  | 7336 | Dinaciclib | Exhibits
  antiviral activity against SARS-CoV-2 in vitro | 
 
  |  | 3807 | Disulfiram | SARS-CoV-2
  Mpro inhibitor; also reversibly stimulates SERCA Ca2+-ATPase | 
 
  |  | 4545 | E 64d | Inhibts
  entry of SARS-CoV-2 into lung cells in combination
  with Camostat (Cat. No. 3193) | 
 
  |  | 5245 | Ebselen | Inhibits
  SARS-CoV-2 Mpro in vitro;
  glutathione peroxidase mimic | 
 
  |  | 6986 | EG
  00229 trifluoroacetate | Inhibits
  binding of cleaved spike protein of SARS-CoV-2 to neuropilin 1 (NRP1) | 
 
  |  | 7231 | EIDD 1931 | Inhibits
  MERS-CoV and SARS-CoV-2 replication in vitro | 
 
  |  | 7225 | Favipiravir | Reduces
  infection rate of SARS-CoV-2 in vitro; viral RNA polymerase inhibitor | 
 
  |  | 3631 | FK 506 | Identified
  as targeting human proteins in the SARS-CoV-2 interactome | 
 
  |  | 7229 | Galidesivir
  dihydrochloride | Broad
  spectrum antiviral nucleotide; inhibits coronavirus replication in vitro | 
 
  |  | 3259 | Gemcitabine
  hydrochloride | Inhibits
  replication of coronaviruses; DNA synthesis inhibitor | 
 
  |  | 7280 | GRL 0617 | Coronavirus
  PLpro inhibitor | 
 
  |  | 7227 | GS 441524 | Displays
  antiviral activity against MERS-CoV, SARS-CoV and SARS-CoV-2 | 
 
  |  | 1416 | Homoharringtonine | Inhibits
  SARS-CoV-2 infection in vitro; inhibits protein synthesis | 
 
  |  | 5648 | Hydroxychloroquine
  sulfate | Inhibits
  SARS-CoV-2 viral infection in vitro | 
 
  |  | 5906 | Imatinib
  mesylate | Inhibits
  replication of SARS-CoV and MERS-CoV in vitro | 
 
  |  | 1708 | Indomethacin | Identified
  as targeting human proteins in the SARS-CoV-2 interactome | 
 
  |  | 1260 | Ivermectin | Inhibits
  replication of SARS-Cov-2 in vitro; antiparasitic and antiviral | 
 
  |  | 2959 | Lercanidipine
  hydrochloride | Exhibits
  anti-MERS-CoV activity in vitro; CaV1.x blocker | 
 
  |  | 3765 | Linezolid | Identified
  as targeting human proteins in the SARS-CoV-2 interactome; antibiotic | 
 
  |  | 0840 | Loperamide
  hydrochloride | Inhibits
  replication of coronaviruses in vitro | 
 
  |  | 7052 | Lopinavir | Inhibits
  SARS-CoV-2 replication in vitro; highly potent and selective HIV-1 protease inhibitor | 
 
  |  | 6819 | Mefloquine
  hydrochloride | Exhibits
  antiviral activities against SARS-CoV-2; also Cx36 and Cx50 gap channel
  blocker | 
 
  |  | 2864 | Metformin
  hydrochloride | Identified
  as targeting human proteins in the SARS-CoV-2 interactome; antidiabetic | 
 
  |  | 7228 | MPro 13b | Coronavirus
  Mpro inhibitor | 
 
  |  | 7230 | MPro N3 | Coronavirus
  Mpro inhibitor | 
 
  |  | 3081 | Nafamostat
  mesylate | Inhibits
  SARS-CoV-2 infection in vitro; serine protease inhibitor | 
 
  |  | 3766 | Nelfinavir
  mesylate | Exhibits
  anti-MERS-CoV activity in vitro; potent HIV-1 protease inhibitor | 
 
  |  | 4079 | Niclosamide | Inhibits
  SARS-CoV-2 spike protein induced syncytia formation and viral
  replication in vitro | 
 
  |  | 7234 | Nitazoxanide | Inhibits
  SARS-CoV-2 infection in vitro | 
 
  |  | 2583 | Omeprazole | Enhances
  anti-SARS-CoV-2 activity of serine protease inhibitors | 
 
  |  | 1076 | Ouabain | Exhibits
  anti-MERS-CoV activity in vitro; Na+/K+ ATPase inhibitor | 
 
  |  | 7357 | PLpro
  inhibitor 6 | SARS-CoV
  and SARS-CoV-2 PLpro inhibitor | 
 
  |  | 1125 | Quercetin | Inhibits
  SARS-CoV Mpro; also non-selective PI 3-kinase inhibitor | 
 
  |  | 1292 | Rapamycin | Inhibits
  MERS-CoV infection; mTOR inhibitor and immunosuppressant | 
 
  |  | 7226 | Remdesivir | Displays
  antiviral activity against MERS-CoV, SARS-CoV and SARS-CoV-2 | 
 
  |  | 4501 | Ribavirin | Inhibits
  cytopathic effect of SARS-CoV in vitro; guanosine analog and IMPDH inhibitor | 
 
  |  | 5856 | Ritonavir | Improves
  outcome in an animal model of MERS-CoV infection; HIV protease inhibitor | 
 
  |  | 7064 | Ruxolitinib | Targets
  human proteins in the SARS-CoV-2 interactome; potent and selective JAK1/JAK2
  inhibitor | 
 
  |  | 7191 | Santacruzamate
  A | Identified
  as targeting human host proteins that interact with SARS-CoV-2 | 
 
  |  | 7189 | Saracatinib | Inhibits
  MERS-CoV, other coronaviruses and dengue virus | 
 
  |  | 7192 | SMIP 004 | S-phase
  kinase-associated protein 2 (SKP2) inhibitor | 
 
  |  | 1138 | Thapsigargin | Inhibits
  SARS-CoV-2 infection in vitro; SERCA inhibitor | 
 
  |  | 2815 | Valproic
  acid, sodium salt | Identified
  as targeting human proteins in the SARS-CoV-2 interactome; HDAC inhibitor | 
 
  |  | 0654 | Verapamil
  hydrochloride | Targets
  human proteins in the SARS-CoV-2 interactome; CaV1.x blocker | 
 
  |  |  |  |  | 
 
  |  | Herpes Simplex Viruses |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 2513 | Acyclovir | Antiviral
  agent; active against herpes simplex viruses | 
 
  |  | 6244 | OG-L002 | Inhibits
  herpes simplex infection in vivo; LSD1 inhibitor | 
 
  |  |  |  |  | 
 
  |  | Cytomegalovirus |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 2457 | Arcyriaflavin A | Inhibits human
  CMV replication in vitro;
  also Cdk4 and CaM kinase II inhibitor | 
 
  |  | 6258 | CC 401 dihydrochloride | Inhibits human CMV replication; JNK inhibitor | 
 
  |  | 2287 | K-252c | Displays antiviral activity against human CMV | 
 
  |  |  |  |  | 
 
  |  | HIV |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 6829 | (R)-Shikonin | Inhibits
  HIV-1 replication | 
 
  |  | 4148 | Abacavir hemisulfate | Inhibits reverse transcriptase (RNA-dependent DNA
  polymerase); antiretroviral | 
 
  |  | 2151 | API-2 | Displays antiviral activity against HIV-1 and -2 | 
 
  |  | 1777 | Arctigenin | Inhibits
  HIV replication in vitro | 
 
  |  | 4150 | Azidothymidine | Selectively inhibits HIV reverse transcriptase
  (RNA-dependent DNA polymerase) | 
 
  |  | 2711 | Bay 55-9837 | Inhibits HIV-1 viral replication; VPAC2 agonist | 
 
  |  | 5009 | BMS 509744 | Inhibits
  HIV infection of primary CD4+ T
  cells | 
 
  |  | 2423 | DAPTA | Inhibits HIV-1 viral cell entry | 
 
  |  | 6710 | Darunavir | Highly potent HIV protease inhibitor | 
 
  |  | 4149 | Delavirdine mesylate | Selectively inhibits HIV reverse transcriptase
  (RNA-dependent DNA polymerase) | 
 
  |  | 7290 | Famotidine | Inhibits
  HIV replication in vitro;
  potent H2 receptor
  inverse agonist | 
 
  |  | 6994 | HODHBt | Reactivates latent HIV-1 reservoir in central memory
  T cells (TCM) | 
 
  |  | 4596 | IT1t dihydrochloride | Blocks interaction of CXCR4 with the HIV envelope
  protein gp120 | 
 
  |  | 6126 | KRH 3955 hydrochloride | Inhibits
  replication of HIV in vitro and in vivo; CXCR4 antagonist | 
 
  |  | 7052 | Lopinavir | Highly potent and selective HIV-1 protease inhibitor | 
 
  |  | 3756 | Maraviroc | Inhibits HIV-1 cell entry; CCR5 antagonist | 
 
  |  | 3766 | Nelfinavir mesylate | Potent HIV-1 protease inhibitor | 
 
  |  | 5856 | Ritonavir | HIV-1 and HIV-2 protease inhibitor | 
 
  |  | 4418 | Saquinavir mesylate | HIV protease inhibitor | 
 
  |  | 4990 | Stavudine | Inhibis
  HIV-1 replication in vitro;
  nucleoside analog | 
 
  |  | 3666 | Tenofovir | Selectively inhibits HIV reverse transcriptase
  (RNA-dependent DNA polymerase) | 
 
  |  |  |  |  | 
 
  |  | Flaviviruses |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 6652 | NGI
  1 | Antiflaviviral;
  active against Zika, West Nile and dengue viruses | 
 
  |  | 6045 | NITD 008 | Antiflaviviral; active against Zika, Dengue and
  Hepatitis C viruses | 
 
  |  |  |  |  | 
 
  |  | Influenza Viruses |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 2404 | Ambroxol hydrochloride | Inhibits
  influenza (H3N2) viral replication; Na+ channel blocker | 
 
  |  | 7225 | Favipiravir | Displays antiviral activity against influenza
  viruses; viral RNA-dependent RNA polymerase inhibitor | 
 
  |  | 3988 | Hesperadin hydrochloride | Displays broad spectrum antiviral activity against
  influenza viruses | 
 
  |  | 7224 | Oseltamivir phosphate | Influenza virus neuraminidase inhibitor; antiviral
  prodrug | 
 
  |  | 4611 | PBP 10 | Displays antiviral activity against influenza viruses | 
 
  |  | 4107 | Probenecid | Inhibits
  influenza A infection in vitro and in vivo; MRP and OAT3 inhibitor | 
 
  |  | 1125 | Quercetin | Non-selective PI 3-kinase inhibitor; blocks cellular
  entry by influenza A virus | 
 
  |  | 1138 | Thapsigargin | Inhibits
  influenza A infection in vitro; SERCA inhibitor | 
 
  |  | 7187 | Zanamivir | Potent influenza virus neuraminidase inhibitor | 
 
  |  |  |  |  | 
 
  |  | Hepatitis Viruses |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 5741 | 25-Hydroxycholesterol | Inhibits
  hepatitis C viral life cycle; also α-crystallin (cryAB) chaperone | 
 
  |  | 6974 | BMS 986094 | Hepatitis C virus RNA-dependent RNA polymerase NS5b
  inhibitor | 
 
  |  | 6234 | Entecavir | Potent and selective hepatitis B reverse
  transcriptase (RNA-dependent DNA polymerase) inhibitor | 
 
  |  | 6045 | NITD 008 | Inhibits cell entry of HCV; also active against
  Dengue and Zika viruses | 
 
  |  | 6658 | Telaprevir | Hepatitis C virus (HCV) protease NS3/4A inhibitor | 
 
  |  |  |  |  | 
 
  |  | Others |  | 
 
  |  | Cat. No. | Product
  Name | Activity | 
 
  |  | 5985 | AKT Inhibitor IV | Displays
  broad antiviral activity against negative-stranded RNA viruses | 
 
  |  | 5736 | Aphidicolin | Antiviral; inhibits DNA polymerase α, β and ε | 
 
  |  | 7235 | Arbidol | Broad spectrum antiviral | 
 
  |  | 2743 | Caffeic acid phenethyl ester | Antiviral; inhibits NF-κB activation | 
 
  |  | 2483 | Costunolide | Antiviral; human telomerase inhibitor | 
 
  |  | 1437 | D609 | Antiviral; PC-PLC inhibitor | 
 
  |  | 5601 | DMXAA | Antiviral; mSTING antagonist | 
 
  |  | 7231 | EIDD 1931 | Viral RNA-dependent RNA polymerase inhibitor; broad
  spectrum antiviral nuceloside prodrug | 
 
  |  | 7342 | Emetine dihydrochloride | Inhibits replication of a broad range of RNA and DNA
  viruses, including SARS-Cov-2 and Zika | 
 
  |  | 6494 | Galangin | Broad spectrum antiviral; induces autophagy and
  inhibits TRPC5 | 
 
  |  | 7229 | Galidesivir dihydrochloride | Broad spectrum antiviral nucleotide; inhibits viral
  RNA-dependent RNA polymerase | 
 
  |  | 7227 | GS 441524 | Viral RNA-dependent RNA polymerase (RdRp) inhibitor | 
 
  |  | 3700 | Imiquimod | Displays antiviral activity; immunomodulator | 
 
  |  | 2307 | Leukotriene B4 | Displays antiviral activity against DNA viruses and
  retroviruses | 
 
  |  | 5604 | MI
  14 | Displays antiviral activity against single-stranded
  positive sense RNA viruses | 
 
  |  | 3117 | Miglustat hydrochloride | Displays broad spectrum antiviral activity;
  α-glucosidase I and II inhibitor | 
 
  |  | 1505 | Mycophenolic acid | Antiviral and immunosuppressant | 
 
  |  | 7234 | Nitazoxanide | Broad spectrum antiviral and antiparasitic | 
 
  |  | 3354 | PF 429242 dihydrochloride | Displays antiviral activity; competitive inhibitor of
  SREBP site 1 protease | 
 
  |  | 7226 | Remdesivir | Broad spectrum antiviral nucelotide prodrug; viral
  RNA-dependent RNA polymerase inhibitor | 
 
  |  | 4536 | Resiquimod | Antiviral and proimflammatory; TLR7 agonist | 
 
  |  | 4501 | Ribavirin | Antiviral guanosine ribonucleoside analog | 
 
  |  | 3356 | WR 1065 dihydrochloride | Displays
  broad spectrum antiviral activity in vitro |